Rigel Pharmaceuticals Inc
NASDAQ:RIGL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Rigel Pharmaceuticals Inc (RIGL) under the Base Case is USD per share.
Compared with the current market price of 42.84 USD, the stock appears .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
What one share is worth in the bear, base and bull cases.
Create a free account · No card needed
Do our valuations actually work? See backtest results .
Intrinsic value next to the price over the past 5 years, and what happened after valuations like today’s.
Create a free account · No card needed
Fundamental Analysis
What Rigel Pharmaceuticals Does
Rigel Pharmaceuticals is a specialty drug company that develops and sells medicines made to treat serious blood, cancer, and immune-related diseases. Its main products are prescription drugs used by doctors and hospitals, with a focus on conditions where patients often need long-term treatment and few good options exist. The company’s work starts in the lab, but it also includes getting medicines approved and bringing them to market.
- Headquarters
- United States of America US
- Employees
- 172
- IPO date
- Nov 29, 2000
Rigel Pharmaceuticals has a wide economic moat
Rigel Pharmaceuticals Inc possesses a wide economic moat, providing strong and durable advantages that protect its market position and profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
Rigel Pharmaceuticals Inc
Earnings Waterfall
Rigel Pharmaceuticals Inc
What is the Intrinsic Value of one RIGL stock?
The intrinsic value for Rigel Pharmaceuticals Inc (RIGL) under the Base Case is USD.
Is RIGL stock undervalued or overvalued?
Compared with the current market price of 42.84 USD, the stock appears .
